Corominas, J., Garriga, C., Prenafeta, A., Moros, A., Cañete, M., Barreiro Vázquez, A., . . . Ferrer, L. (2023). Safety and immunogenicity of the protein-based PHH-1V compared to BNT162b2 as a heterologous SARS-CoV-2 booster vaccine in adults vaccinated against COVID-19.
Citación estilo ChicagoCorominas, Júlia, et al. Safety and Immunogenicity of the Protein-based PHH-1V Compared to BNT162b2 As a Heterologous SARS-CoV-2 Booster Vaccine in Adults Vaccinated against COVID-19. 2023.
Cita MLACorominas, Júlia, et al. Safety and Immunogenicity of the Protein-based PHH-1V Compared to BNT162b2 As a Heterologous SARS-CoV-2 Booster Vaccine in Adults Vaccinated against COVID-19. 2023.
Precaución: Estas citas no son 100% exactas.